Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05109 (
S100A8
)
1,212
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neutrophil NADPH oxidase (
NOX2
) is a key enzyme responsible for host defense against invading pathogens, via the production of reactive oxygen species. Dysfunction of
NOX2
can contribute to inflammatory processes, which could lead to the development of diseases such as atherosclerosis. In this paper, we characterize a pathway leading to
NOX2
activation in which iPLA(2)-regulated p38 MAPK activity is a key regulator of
S100A8
/A9 translocation via S100A9 phosphorylation. Studies in cell-free or recombinant systems involved two Ca2+-binding proteins of the S100 family, namely
S100A8
and S100A9, in
NOX2
activation dependent on intracellular Ca2+ concentration ([Ca2+](i)) elevation. Using differentiated HL-60 cells as a model of neutrophils, we provide evidence that [Ca2+](i)-regulated
S100A8
/A9 translocation is mediated by an increase in [Ca2+](i) through intracellular Ca2+ store depletion. Moreover, we confirm that p38 MAPK induces S100A9 phosphorylation, a mandatory precondition for S100 translocation. Based on a pharmacological approach and an siRNA strategy, we identify iPLA(2) as a new molecular player aiding S100 translocation and
NOX2
activity. Inhibition of p38 MAPK activity and S100A9 phosphorylation by bromoenol lactone, a selective inhibitor of iPLA(2), indicated that p38 MAPK-mediated S100A9 phosphorylation is dependent on iPLA(2). In conclusion, we have characterized a pathway leading to
NOX2
activation in which iPLA(2)-regulated p38 MAPK activity is a key regulator of
S100A8
/A9 translocation via S100A9 phosphorylation.
...
PMID:iPLA2, a novel determinant in Ca2+- and phosphorylation-dependent S100A8/A9 regulated NOX2 activity. 2021 70
Neutrophils play a fundamental role in host defense by neutralizing pathogens through the generation of ROS by
NOX2
. In nonexcitable cells, Ca(2+) influx is essentially mediated via SOCE, a complex mechanism in which depletion of intracellular Ca(2+) stores from the ER results in Ca(2+) entry through Ca(2+) SOCs at the plasma membrane. In this regard, it is well established that extracellular Ca(2+) entry participates to
NOX2
activation. S1P, produced by SphKs, has been involved in Ca(2+) homeostasis and thus, could intervene in
NOX2
regulation. The aim of this study was to characterize the importance of SphKs in
NOX2
activation and the signaling cascade involved in this mechanism. Treatment of neutrophil-like dHL-60 cells by DHS, a SphK inhibitor, and SphK siRNA inhibited fMLF-induced
NOX2
activity. Sequential activation of cells by thapsigargin and the phorbol ester PMA revealed that SphK-regulated
NOX2
activity relies on intracellular Ca(2+) store depletion. Confocal microscopy and immunoblot analysis showed that stimulation by thapsigargin and PMA mediated
S100A8
/A9 recruitment to the plasma membrane and p38 MAPK activation.
S100A8
/A9 translocation decreased when SphK activity was blocked. This result was confirmed in purified human neutrophils, which were physiologically stimulated by fMLF. In addition, p38 MAPK was found to be regulated by SphKs. These results define a pathway leading to
NOX2
activation, in which p38 MAPK-mediated
S100A8
/A9 translocation is regulated by Ca(2+) store depletion-dependent SphK activation.
...
PMID:Sphingosine kinases regulate NOX2 activity via p38 MAPK-dependent translocation of S100A8/A9. 2123 11